Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Karl Gaff"'
Autor:
Walter P. Maksymowych, Howard Thom, Michael F. Mørup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 1023-1041 (2024)
Abstract Introduction A previous network meta-analysis established 16-week relative efficacy with bimekizumab, an inhibitor of interleukin (IL)-17F in addition to IL-17A, versus other treatments for patients with radiographic axial spondyloarthritis
Externí odkaz:
https://doaj.org/article/4b878f98b5e34d09a94b0e709d45235c
Autor:
Annelies Boonen, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Karl Gaffney, Maureen Dubreuil, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Thomas Vaux, Michael F Mørup, Christine de la Loge
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective To assess the impact of bimekizumab on physical functioning, sleep, work productivity and overall health-related quality of life (HRQoL) in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA) in the ph
Externí odkaz:
https://doaj.org/article/6e49044faaf046c4839ca01e2aea5e2a
Autor:
Nurullah Akkoç, Carlos H. Arteaga, Simone E. Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J. Mease
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 307-327 (2023)
Abstract Introduction Biologic disease-modifying anti-rheumatic drugs (bDMARDs), including certolizumab pegol (CZP), are effective treatment options for the management of non-radiographic spondyloarthritis (nr-axSpA). In the absence of head-to-head c
Externí odkaz:
https://doaj.org/article/2ac7e2053157492b9c3f150d1bdbe02c
Autor:
Michelle Peckham, Karl Gaff, Alistair Curd, Martijn A. Huynen, Oliver E. Blacque, Ka Man Wu, Colin A. Johnson, Laurence Faivre, Rachel H. Giles, Diane Doummar, Nils J. Lambacher, Tania Attié-Bitach, Lydie Burglen, Gisela G. Slaats, Christel Thauvin-Robinet, Ange-Line Bruel, Gavin J. McManus, Katarzyna Szymanska, Sophie Saunier, Julie Kennedy, Teunis J. P. van Dam, Robin van der Lee, Jean-Baptiste Rivière, Stefanie Kuhns
Publikováno v:
Nature Cell Biology, 18, 122-31
Nature Cell Biology
Nature Cell Biology, Nature Publishing Group, 2016, 18 (1), pp.122-131. 〈10.1038/ncb3273〉
Nature Cell Biology, Nature Publishing Group, 2016, 18 (1), pp.122-131. ⟨10.1038/ncb3273⟩
Nature Cell Biology, 18, 1, pp. 122-31
Nature Cell Biology
Nature Cell Biology, Nature Publishing Group, 2016, 18 (1), pp.122-131. 〈10.1038/ncb3273〉
Nature Cell Biology, Nature Publishing Group, 2016, 18 (1), pp.122-131. ⟨10.1038/ncb3273⟩
Nature Cell Biology, 18, 1, pp. 122-31
Item does not contain fulltext The transition zone (TZ) ciliary subcompartment is thought to control cilium composition and signalling by facilitating a protein diffusion barrier at the ciliary base. TZ defects cause ciliopathies such as Meckel-Grube
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5843950ab0be0a0ffe94ae9a58df2d06
https://dspace.library.uu.nl/handle/1874/332912
https://dspace.library.uu.nl/handle/1874/332912
Publikováno v:
Imaging Marine Life: Macrophotography and Microscopy Approaches for Marine Biology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23a28b69b3de9552ffcf2fa6d9a327b1
https://doi.org/10.1002/9783527675418.ch5
https://doi.org/10.1002/9783527675418.ch5
Autor:
Robert Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, Lianne S. Gensler
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 3, Pp 581-599 (2020)
Abstract Introduction Achievement of remission is a key treatment goal for patients with axial spondyloarthritis (axSpA). C-OPTIMISE assessed achievement of sustained clinical remission in patients with axSpA, including radiographic (r) and non-radio
Externí odkaz:
https://doaj.org/article/d24ddd10a84d4d3dac2c84f1bf9d36df
Autor:
Himanshu Pathak, Karl Gaffney
Publikováno v:
Indian Journal of Rheumatology, Vol 15, Iss 5, Pp 34-39 (2020)
Spondyloarthritis (SpA) comprises a group of related diseases which share similar pathogenesis and clinical manifestations. Although the occurrence of SpA spectrum disorders has been known for some time, it was only in the latter half of the twentiet
Externí odkaz:
https://doaj.org/article/4eb3f50e0ffe4ca1ae784d0b3b6145f3
Autor:
Gary J. Macfarlane, Ejaz Pathan, Stefan Siebert, Jonathan Packham, Karl Gaffney, Ernest Choy, Raj Sengupta, Fabiola Atzeni, Kathryn R. Martin, Gareth T. Jones, Linda E. Dean
Publikováno v:
BMC Rheumatology, Vol 3, Iss 1, Pp 1-11 (2019)
Abstract Background Around 1 in 8 patients with axial spondyloarthritis (axSpA) also meet criteria for fibromyalgia and such patients have considerable unmet need. Identifying effective therapy is important but to what extent fibromyalgia-like sympto
Externí odkaz:
https://doaj.org/article/1d4fddc2d0644eb7ae207fe3003ba483
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Objectives Extra-articular manifestations (EAMs) are important systemic features of axial spondyloarthritis (axSpA), which may influence the choice of tumour necrosis factor-inhibitor (TNFi). We examined the cumulative incidence and predictors of EAM
Externí odkaz:
https://doaj.org/article/06df5a23d788496a8e07bdd61326a722
Publikováno v:
Indian Journal of Rheumatology, Vol 12, Iss 2, Pp 112-113 (2017)
Externí odkaz:
https://doaj.org/article/365af6c8b55249fe8da125482386f381